Guidelines for the Management of Patients with Crohn's Disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology

Overview

Journal Prz Gastroenterol

Publisher Termedia

Specialty Gastroenterology

Date 2022 Jan 3

PMID 34976235

Citations 22

Authors

Michal Lodyga

Piotr Eder

Magdalena Gawron-Kiszka

Agnieszka Dobrowolska

Maciej Gonciarz

Marek Hartleb

Maria Klopocka

Ewa Malecka-Wojciesko

Piotr Radwan

Jaroslaw Regula

Edyta Zagorowicz

Grazyna Rydzewska

Affiliations

Soon will be listed here.

Abstract

This paper is an update of the diagnostic and therapeutic recommendations of the National Consultant for Gastroenterology and the Polish Society of Gastroenterology from 2012. It contains 46 recommendations for the diagnosis and treatment, both pharmacological and surgical, of Crohn's disease in adults. The guidelines were developed by a group of experts appointed by the Polish Society of Gastroenterology and the National Consultant in the field of Gastroenterology. The methodology related to the GRADE methodology was used to assess the quality and strength of the available recommendations. The degree of expert support for the proposed statement, assessment of the quality of evidence and the strength of the recommendation was assessed on a 6-point Likert scale. Voting results, quality and strength ratings with comments are included with each statement.

Citing Articles

Preoperative Optimization of Crohn's Patients before Abdominopelvic Surgery.

Moussally M, Paski S, Cohen B, Holubar S Clin Colon Rectal Surg. 2025; 38(2):85-95.

PMID: 39944311 PMC: 11813612. DOI: 10.1055/s-0044-1786380.

Ophthalmological manifestations in inflammatory bowel disease under the watchful eye of a gastroenterologist from a tertiary centre.

Lewandowski K, Kaniewska M, Karlowicz K, Wiecek M, Tulewicz-Marti E, Celmer P Prz Gastroenterol. 2025; 16(4):397-407.

PMID: 39810871 PMC: 11726220. DOI: 10.5114/pg.2024.144988.

Von Meyenburg complexes as an incidental finding in a patient with Crohn's disease.

Frak W, Domzal-Magrowska D, Malecka-Wojciesko E Prz Gastroenterol. 2025; 16(4):454-455.

PMID: 39810870 PMC: 11726229. DOI: 10.5114/pg.2024.145538.

Appraisal of current surgical guidelines for inflammatory bowel disease using the AGREE-S instrument: A scoping review.

Khan Z, Ball C, Saeed D, Tai G, Chandran S, Vashista A Colorectal Dis. 2024; .

PMID: 39658521 PMC: 11683313. DOI: 10.1111/codi.17258.

Evaluation of Selenium Concentrations in Patients with Crohn's Disease and Ulcerative Colitis.

Chalcarz M, Grabarek B, Sirek T, Sirek A, Ossowski P, Wilk M Biomedicines. 2024; 12(10).

PMID: 39457481 PMC: 11505140. DOI: 10.3390/biomedicines12102167.

References

Danese S, Fiorino G, Raine T, Ferrante M, Kemp K, Kierkus J . ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update. J Crohns Colitis. 2016; 11(1):26-34. DOI: 10.1093/ecco-jcc/jjw198. View

Yang Z, Clark N, Park K . Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children. Clin Gastroenterol Hepatol. 2013; 12(2):253-62.e2. PMC: 3865226. DOI: 10.1016/j.cgh.2013.06.028. View

Liu W, Liu J, Xiao W, Luo G . A Diagnostic Accuracy Meta-analysis of CT and MRI for the Evaluation of Small Bowel Crohn Disease. Acad Radiol. 2017; 24(10):1216-1225. DOI: 10.1016/j.acra.2017.04.013. View

Katz L, Gisbert J, Manoogian B, Lin K, Steenholdt C, Mantzaris G . Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response. Inflamm Bowel Dis. 2012; 18(11):2026-33. DOI: 10.1002/ibd.22902. View

Rutgeerts P, Gasink C, Chan D, Lang Y, Pollack P, Colombel J . Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease. Gastroenterology. 2018; 155(4):1045-1058. DOI: 10.1053/j.gastro.2018.06.035. View

Chhaya V, Saxena S, Cecil E, Subramanian V, Curcin V, Majeed A . Impact of timing and duration of thiopurine treatment on first perianal surgery in Crohn's disease: UK population-based study (1995-2009). Inflamm Bowel Dis. 2015; 21(2):385-91. DOI: 10.1097/MIB.0000000000000290. View

Wynne B, McHugh L, Gao W, Keegan D, Byrne K, Rowan C . Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel Diseases. Gastroenterology. 2018; 156(4):935-945.e1. DOI: 10.1053/j.gastro.2018.11.030. View

Nahon S, Lahmek P, Lesgourgues B, Poupardin C, Chaussade S, Peyrin-Biroulet L . Diagnostic delay in a French cohort of Crohn's disease patients. J Crohns Colitis. 2014; 8(9):964-9. DOI: 10.1016/j.crohns.2014.01.023. View

Gordon M, Naidoo K, Thomas A, Akobeng A . Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease. Cochrane Database Syst Rev. 2011; (1):CD008414. DOI: 10.1002/14651858.CD008414.pub2. View

10.

Bar Yehuda S, Axlerod R, Toker O, Zigman N, Goren I, Mourad V . The Association of Inflammatory Bowel Diseases with Autoimmune Disorders: A Report from the epi-IIRN. J Crohns Colitis. 2018; 13(3):324-329. DOI: 10.1093/ecco-jcc/jjy166. View

11.

Greuter T, Piller A, Fournier N, Safroneeva E, Straumann A, Biedermann L . Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors, and Disease Course. J Crohns Colitis. 2018; 12(12):1399-1409. DOI: 10.1093/ecco-jcc/jjy121. View

12.

Morar P, Faiz O, Warusavitarne J, Brown S, Cohen R, Hind D . Systematic review with meta-analysis: endoscopic balloon dilatation for Crohn's disease strictures. Aliment Pharmacol Ther. 2015; 42(10):1137-48. DOI: 10.1111/apt.13388. View

13.

Dignass A, Stoynov S, Dorofeyev A, Grigorieva G, Tomsova E, Altorjay I . Once versus three times daily dosing of oral budesonide for active Crohn's disease: a double-blind, double-dummy, randomised trial. J Crohns Colitis. 2014; 8(9):970-80. DOI: 10.1016/j.crohns.2014.01.021. View

14.

Ghosh S, Iacucci M . Role of immunosuppressives in special situations: perianal disease and postoperative period. Dig Dis. 2014; 32 Suppl 1:92-5. DOI: 10.1159/000367835. View

15.

Schoepfer A, Dehlavi M, Fournier N, Safroneeva E, Straumann A, Pittet V . Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate. Am J Gastroenterol. 2013; 108(11):1744-53. DOI: 10.1038/ajg.2013.248. View

16.

Echarri A, Castro J, Barreiro M, Carpio D, Pereira S, Lorenzo A . Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure. J Crohns Colitis. 2010; 4(6):654-60. DOI: 10.1016/j.crohns.2010.07.012. View

17.

Davidov Y, Ungar B, Bar-Yoseph H, Carter D, Haj-Natour O, Yavzori M . Association of Induction Infliximab Levels With Clinical Response in Perianal Crohn's Disease. J Crohns Colitis. 2017; 11(5):549-555. DOI: 10.1093/ecco-jcc/jjw182. View

18.

Tavernier N, Fumery M, Peyrin-Biroulet L, Colombel J, Gower-Rousseau C . Systematic review: fertility in non-surgically treated inflammatory bowel disease. Aliment Pharmacol Ther. 2013; 38(8):847-53. DOI: 10.1111/apt.12478. View

19.

DHaens G, Vermeire S, Lambrecht G, Baert F, Bossuyt P, Pariente B . Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease. Gastroenterology. 2018; 154(5):1343-1351.e1. DOI: 10.1053/j.gastro.2018.01.004. View

20.

Kennedy N, Clark A, Walkden A, Chang J, Fasci-Spurio F, Muscat M . Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50 years. J Crohns Colitis. 2014; 9(1):41-9. PMC: 4795527. DOI: 10.1016/j.crohns.2014.07.005. View